Atlas Trials

The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis

Clinical trial NCT06609447 · RECRUITING

Trial details

NCT number
NCT06609447
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2024-09-21
Primary completion
2027-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.